Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
Todd C. Lee(McGill University Health Centre), Emily G. McDonald(McGill University Health Centre), Zahra Sohani(McGill University), Julien Senécal(McGill University Health Centre), Olivier Del Corpo(McGill University), James M. Brophy(McGill University Health Centre), Guillaume Butler‐Laporte(Royal Victoria Hospital), Srinivas Murthy
Cited by 89
Related Papers
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
|New England Journal of Medicine|2020|1.4k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19
|Annals of Internal Medicine|2020|548